highlight / actuality
The study carried out by researchers in our laboratory shows for the first time that microRNA miR-483-5p, dosed in the 3 months after surgery, is a powerful biomarker for the prognosis of the Adrenocortical Carcinoma. This test would allow the non-invasive monitoring of patients with this cancer and offers the prospect of integrating miRs into routine care for the diagnosis/prognosis of this type of carcinoma in the future.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.